The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): translation and validation study of the Iranian version
The DOI matches its Crossref record; 16 of the 17 references it cites were found in a registry or an index.
Abstract
The objective of this study was to test the reliability and validity of the Iranian version of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ-C30). The English-language version of the questionnaire was translated into Persian (Iranian language), and its final form was approved by the EORTC Study Group on Quality of Life before it was used in this study. The questionnaire was administered at two time points to a consecutive sample of 168 newly diagnosed breast cancer patients, and almost all of them (99%) found the questions easy to understand and acceptable. Crohnbach's alpha coefficient for multi-item scales (to test reliability) ranged from 0.48 to 0.95 at baseline and from 0.52 to 0.98 at follow-up administration of the questionnaire. Validity was checked using two methods: inter-scale correlation and known-groups comparison. Almost all inter-scale correlations were statistically significant in the expected direction. Known-groups comparison analysis showed that all functioning and symptom scales discriminated between subgroups of patients differing in clinical status as defined by their performance status and disease stage. In general, the findings of this study indicate that the Iranian version of the EORTC QLQ-C30 is a reliable and valid measure of quality of life in cancer patients and can be used in clinical trials and studies of outcome research in oncology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Also, the Persian version of QOL of Cancer Patients (QLQ-C30) was previously validated in Iranian patients (Cronbach α for its subscales measured from 0.48 to 0.89).27”
From A randomized clinical trial: Efficacy of group-based acceptance and commitment therapy program for breast cancer patients with high fear of progression (2024) · cites this paper as [27]
Citations
Cites
Coefficient Alpha and the Internal Structure of Tests
Cronbach, L. J. (1951) · Psychometrika · doi:10.1007/bf02310555 · Cited by 43,931 · cited 1×
“The internal consistency of the multi-item scales was assessed by Cronbach’s alpha coefficient [10].”
MethodAaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005 · cited 14×
“It is argued that the best developed quality of life measure for use with cancer patients is currently the EORTC QLQ-C30 [6].”
BackgroundMethodResultInfluentialFoundations of Behavioral Research
Stockton, R., & Kerlinger, F. N. (1974) · American Educational Research Journal · doi:10.2307/1162206 · Cited by 7,347 · cited 1×
“Second, the method of known-groups comparison was used to evaluate the extent to which the QLQ-C30 was able to discriminate between subgroups of patients differing in clinical status [ 16 ].”
MethodA Critical Appraisal of the Quality of Quality-of-Life Measurements
Gill, T. M. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03520080061045 · Cited by 2,208
Brady, M. J., Cella, D. F., Mo, F., Bonomi, A. E., Tulsky, D. S., Lloyd, S. R., Deasy, S., Cobleigh, M., & Shiomoto, G. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.3.974 · Cited by 1,752
Sprangers, M. A., Groenvold, M., Arraras, J. I., Franklin, J., te Velde, A., Muller, M., Franzini, L., Williams, A., de Haes, H. C., Hopwood, P., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2756 · Cited by 1,220 · cited 1×
“Despite the cultural differences that exist between Europe and Asia, in our centre (Iranian Centre for Breast Cancer-ICBC) we decided to translate the English-language version of the QLQ-C30 and its supplementary breast-cancer-specific instrument (QLQ-BR23) [22] into Persian (Iranian language) for the first time, for…”
MethodZubrod, C. G., Schneiderman, M., Frei, E., Brindley, C., Lennard Gold, G., Shnider, B., Oviedo, R., Gorman, J., Jones, R., Jonsson, U., et al. (1960) · Journal of Chronic Diseases · doi:10.1016/0021-9681(60)90137-5 · Cited by 1,034 · cited 1×
“Zero indicates that the patient is able to carry out all normal activities and 4, that the patient is completely disabled [24].”
BackgroundMeasuring Disease: A Review of Disease-Specific Quality of Life Measurement Scales
Bowling, A. (1995) · Research Repository (Kingston University London) · Cited by 731
Sprangers, M. A. G., Cull, A., Bjordal, K., Groenvold, M., Aaronson, N. K., & EORTC Study Group on Quality of Life (1993) · Quality of Life Research · doi:10.1007/bf00434800 · Cited by 514
Bowling, A. (1995) · Social Science & Medicine · doi:10.1016/0277-9536(95)00113-l · Cited by 509 · cited 1×
“Measuring quality of life in cancer patients is rapidly becoming more widespread, although some conceptual and methodological issues remain to be settled [7, 13, 18, 20].”
BackgroundA Modular Approach to Quality-of-Life Assessment in Cancer Clinical Trials
Aaronson, N. K., Bullinger, M., & Ahmedzai, S. (1988) · Recent Results in Cancer Research · doi:10.1007/978-3-642-83419-6_27 · Cited by 414 · cited 1×
“The EORTC QLQ-C30 is a 30-item core-cancer-specific questionnaire measuring quality of life in cancer patients, and the conceptual and methodological issues underlying the construction of the questionnaire are described in detail elsewhere by the workers who pioneered it [1, 2].”
BackgroundCross-cultural adaptation of health measures
Hunt, S. M., Alonso, J., Bucquet, D., Niero, M., Wiklund, I., & McKenna, S. (1991) · Health Policy · doi:10.1016/0168-8510(91)90072-6 · Cited by 311 · cited 1×
“Although it is argued that the process of producing high-quality translation of quality of life questionnaires can be extremely complex and time consuming [14, 15 ], there is increasing interest in the translation and validation of health status questionnaires [5, 8, 9]. This paper reports the findings recorded in a v…”
MethodSprangers, M. A. G., Cull, A., Groenvold, M., Bjordal, K., Blazeby, J. M., & Aaronson, N. K. (1998) · Quality of Life Research · doi:10.1023/a:1024977728719 · Cited by 277
Kobayashi, K., Takeda, F., Teramukai, S., Gotoh, I., Sakai, H., Yoneda, S., Noguchi, Y., Ogasawara, H., & Yoshida, K. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00395-x · Cited by 256 · cited 2×
“vances in measuring quality of life in clinical research worldwide and in countries such as Japan [17], it is not surprising that to our knowledge this is the first study of its type in Iran.”
BackgroundThe EORTC Core Quality-of-Life Questionnaire: Interim Results of an International Field Study *
Aaronson, N. K., Ahmedzai, S., Bullinger, M., Crabeels, D., Estapè, J., Filiberti, A., Flechtner, H., Frick, U., Hürny, C., Kaasa, S., et al. (2021) · Effect of Cancer on Quality of Life · doi:10.1201/9781003068648-14 · Cited by 157
Quality of life: Perception of lung cancer patients
Montazeri, A., Milroy, R., Gillis, C. R., & McEwen, J. (1996) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00288-2 · Cited by 39 · cited 1×
“Measuring quality of life in cancer patients is rapidly becoming more widespread, although some conceptual and methodological issues remain to be settled [7, 13, 18 , 20].”
BackgroundSelf-citation
Cited by
(2003) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-1-14 · Cited by 640
Self-citationMontazeri, A., Harirchi, A. M., Shariati, M., Garmaroudi, G., Ebadi, M., & Fateh, A. (2003) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-1-66 · Cited by 606
Self-citationPommier, P., Chabaud, S., Lagrange, J. L., Richaud, P., Lesaunier, F., Le Prise, E., Wagner, J. P., Hay, M. H., Beckendorf, V., Suchaud, J. P., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.5171 · Cited by 340
Montazeri, A., Vahdaninia, M., Harirchi, I., Ebrahimi, M., Khaleghi, F., & Jarvandi, S. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-330 · Cited by 283
“The psychometric properties of the Iranian version of both questionnaires are well documented [10,11].”
Self-citationWhat do predict anxiety and depression in breast cancer patients? A follow-up study
Vahdaninia, M., Omidvari, S., & Montazeri, A. (2010) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-009-0068-7 · Cited by 275
“The psychometric properties of the Iranian version of EORTC QLQ-C30 questionnaire are confirmed [24].”
MethodSelf-citation
Metadata
- Authors
- Montazeri, A., Harirchi, I., Vahdani, M., Khaleghi, F., Jarvandi, S., Ebrahimi, M., & Haji-Mahmoodi, M.
- Venue
- Supportive Care in Cancer
- Published
- 1999-10-11
- Volume
- 7
- Issue
- 6
- Pages
- 400-406
- ISSN
- 0941-4355 (ISSN-L)
- 1433-7339
- OpenAlex
- W2074668580
- Cited by
- 176
- References
- 17
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 10 · 2023: 8 · 2022: 13 · 2021: 14 · 2020: 12 · 2019: 10 · 2018: 8 · 2017: 10 · 2016: 4 · 2015: 9 · 2014: 9 · 2013: 7 · 2012: 12
- FWCI
- 0.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Supportive Care in Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Nursing › Research and Theory › Health Education and Validation
- Keywords
- EORTC QLQ-C30, quality of life, breast cancer, Persian translation, cross-cultural adaptation, psychometric validation, reliability statistics, known-groups comparison, cancer patients, Iranian patients
- MeSH terms
- Activities of Daily Living, Adult, Aged, Aged, 80 and over, Analysis of Variance, Breast Neoplasms, Clinical Trials as Topic, Cognition, Emotions, Female, Follow-Up Studies, Humans, Iran, Language, Middle Aged, Neoplasm Staging, Quality of Life, Surveys and Questionnaires, Role, Social Adjustment, Reproducibility of Results, Outcome Assessment, Health Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.